Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundEffective treatments for cognitive impairment in Parkinsons's disease (PD) are needed, with Greater Occipital Nerve Stimulation (GONS) emerging as a potential therapeutic approach. This study aimed to explore PD patients' attitudes toward GONS and assess its safety and tolerability in an open-label field study.MethodsA two-stage study was carried out, comprising an online survey to gather self-reported attitudes from individuals with PD toward GONS as a treatment option, followed by an open-label field study evaluating the safety, tolerability, and acceptability of GONS in PD-MCI patients.ResultsOf 50 survey participants, 86% expressed willingness to try GONS for cognitive impairment. Five participants completed the GONS intervention, which was found to be safe, well-tolerated, and acceptable.ConclusionPeople with PD are open to novel interventions for cognitive impairment. GONS was shown to be safe and well-tolerated, warranting further investigation as a potential therapeutic approach.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.